Ann: Quarterly Activities Report & Appendix 4C, page-15

Those who have invested in this company and who understand the realities of starting a new business in a new market with numerous regulatory hurdles to overcome will recognise that CPH have made huge headway in establishing the basis for a very successful business.

They have some serious projects underway in both human and animal health, with markets already opening up for these products, and they are well on the way to becoming a significant cannabis producer with growing facilities in Canada and Columbia. The completion of the Kunna deal is a major step forward, and opens up new markets and cost saving opportunities, as well as a new research and product development channel for CPH.

Even a little very basic unbiased research into CPH will show that it has made much greater progress than most of its Australian rivals, some of which have considerably higher market caps and share prices. This company looks like very good value to me at the current SP.